NCT01544673View on ClinicalTrials.gov

Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Males

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Gram Positive Infection

Interventions

DRUG

linezolid

600 mg oral tablet twice daily for 4.5 days

DRUG

Placebo

500 mg oral placebo twice daily for 4.5 days

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT01544673 - Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Males | Biotech Hunter | Biotech Hunter